Trials / Conditions / Advanced Hodgkin Lymphoma
Advanced Hodgkin Lymphoma
5 registered clinical trials studyying Advanced Hodgkin Lymphoma — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | PET-Adapted First-Line Therapy With Nivolumab for Advanced Hodgkin Lymphoma NCT07209059 | National Research Center for Hematology, Russia | Phase 2 |
| Recruiting | BrECADD Therapy in Stage 2 B-IV Hodgkin Lymphoma NCT07002216 | University of Miami | Phase 2 |
| Recruiting | Personalized Reduction of Chemotherapy Intensity Through ctDNA Evaluation for the Treatment of Patients With A NCT06745076 | University of Washington | Phase 2 |
| Active Not Recruiting | Very Early PET-response Adapted Targeted Therapy for Advanced Hodgkin Lymphoma: a Single -Arm Phase II Study NCT03517137 | European Organisation for Research and Treatment of Cancer - EORTC | Phase 2 |
| Completed | Brentuximab Vedotin with Adriamycin, Vinblastine and Dacarbazine for Patients Aged 18-59 Years with Untreated NCT06857500 | Federico II University | — |